Global Report Life Sciences

23-Valent Pneumococcal Polysaccharide Vaccine Market—Global Forecast 2026

consainsights.com
23-Valent Pneumococcal Polysaccharide Vaccine Market by Dose Type, Age-group, Region, Trends, Competitive Analysis, and Growth Opportunities, Key Insights.

Overview

23-Valent Pneumococcal Polysaccharide Vaccine Market from Consainsights analyses the 23-Valent Pneumococcal Polysaccharide Vaccine Market in the Life Sciences industry over the forecast period to 2026.

23-Valent Pneumococcal Polysaccharide Vaccine research report from Consainsights outlines the detailed strategic analysis, trends, market opportunities, growth prospects, industry and market challenges and sustainable solutions to sustain in the competitive environment.

23-Valent Pneumococcal Polysaccharide Vaccine segmentation includes Dose Type, Age-group and Geography.

Market analysis on the basis of Dose Type include SINGLE DOSE VIAL, PRE-FILLED SYRINGE. This segmentation encompasses the key innovations and micro & macro trends, companies/manufacturers operating in this space along with their usage and penetration with respect to the wide range of End Users. Additionally, market sizing information along with the key factors such as market drivers, restraints, opportunities and challenges which are likely to be influencing the market growth are outlined in this report.

Based on the Age-group, the 23-Valent Pneumococcal Polysaccharide Vaccine Market analysis covers CHILDREN (2-10 YEARS), ADULTS (10-64 YEARS), GERIATRICS (65 YEARS AND ABOVE).

Key companies operating in the market include PFIZER INC., SANOFI S.A., GLAXOSMITHKLINE PLC, MERCK & CO., ASTRAZENECA, BAXTER INTERNATIONAL INC., BEIJING MINHAI BIOTECHNOLOGY and so on. This report covers the detailed analysis of the company profiles such as business segments, product portfolio, key brand insights and growth strategies adopted, company SWOT and Strategy analysis along with the financial analysis and analyst insights on the key companies operating in this market.

Moreover, the competitive analysis includes the companies deals such as Mergers, Acquisitions, Partnerships and so on along with the expansion areas focusing on the additional geographies, future insights for success and market share analysis. Major players strategies include the launch of the innovative product lines along with the emphasis on the partnerships and acquisitions to standardize their market share in the market space.

Market Research methodology includes the triangulation of the data from the data sources such as Primary Market Research approach and Secondary Market Research Approach along with the data from the trade bodies and industry standard publications and data sources. Primary inputs from the industry experts and the market respondents from the respective industries to obtain very critical information to assess the future growth prospects of the market. The final data is triangulated and thoroughly validated considering all the data sources using the bottom-up and the top-down approaches to estimate the market sizing of the individual segments.

The 23-Valent Pneumococcal Polysaccharide Vaccine Market is segmented into the following categories:

23-Valent Pneumococcal Polysaccharide Vaccine Market by Dose Type:

  • SINGLE DOSE VIAL
  • PRE-FILLED SYRINGE

23-Valent Pneumococcal Polysaccharide Vaccine Market by Age-group:

  • CHILDREN (2-10 YEARS)
  • ADULTS (10-64 YEARS)
  • GERIATRICS (65 YEARS AND ABOVE)

Table of Contents

  1. Executive Summary

  2. 23-Valent Pneumococcal Polysaccharide Vaccine Market Overview

    1. 23-Valent Pneumococcal Polysaccharide Vaccine Market Definition & Scope
    2. Currency, Year and Forecasts Overview
    3. 23-Valent Pneumococcal Polysaccharide Vaccine Market 360° Synopsis: Overview
  3. 23-Valent Pneumococcal Polysaccharide Vaccine Industry Analysis

    1. Industry Value Chain Analysis
    2. Key Companies at each phase of Value Chain
    3. Industry Trend Analysis
  4. 23-Valent Pneumococcal Polysaccharide Vaccine Market Analysis

    1. Drives, Restraints, Opportunities and Challenges Impact Analysis
    2. Porter’s Five Force Model Analysis
    3. PESTLE Analysis
    4. BPS Analysis
    5. 23-Valent Pneumococcal Polysaccharide Vaccine Market Key Innovation & Trends
    6. Pricing Patterns (Company & Product Type)
  5. 23-Valent Pneumococcal Polysaccharide Vaccine Market: Dose Type

    1. Introduction
    2. SINGLE DOSE VIAL: Market Trends, Size, and Forecast (2017-2026)
    3. PRE-FILLED SYRINGE: Market Trends, Size, and Forecast (2017-2026)
  6. 23-Valent Pneumococcal Polysaccharide Vaccine Market: Age-group

    1. Introduction
    2. CHILDREN (2-10 YEARS): Market Trends, Size, and Forecast (2017-2026)
    3. ADULTS (10-64 YEARS): Market Trends, Size, and Forecast (2017-2026)
    4. GERIATRICS (65 YEARS AND ABOVE): Market Trends, Size, and Forecast (2017-2026)
  7. Global Analysis

    1. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Region, Y-O-Y Growth Analysis

      1. Introduction
      2. North America: Market Trends, Size, and Forecast (2017-2026)
      3. Europe: Market Trends, Size, and Forecast (2017-2026)
      4. Asia-Pacific: Market Trends, Size, and Forecast (2017-2026)
      5. Latin America: Market Trends, Size, and Forecast (2017-2026)
      6. Middle East & Africa: Market Trends, Size, and Forecast (2017-2026)
  8. North America Analysis

    1. North America 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Country, Y-O-Y Growth Analysis

      1. Introduction
      2. United States: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. United States 23-Valent Pneumococcal Polysaccharide Vaccine Market: Dose Type
        3. United States 23-Valent Pneumococcal Polysaccharide Vaccine Market: Age-group
      3. Canada: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Canada 23-Valent Pneumococcal Polysaccharide Vaccine Market: Dose Type
        3. Canada 23-Valent Pneumococcal Polysaccharide Vaccine Market: Age-group
    2. North America 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Dose Type, Y-O-Y Growth Analysis

      1. Introduction
      2. SINGLE DOSE VIAL: Market Trends, Size, and Forecast (2017-2026)
      3. PRE-FILLED SYRINGE: Market Trends, Size, and Forecast (2017-2026)
    3. North America 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Age-group, Y-O-Y Growth Analysis

      1. Introduction
      2. CHILDREN (2-10 YEARS): Market Trends, Size, and Forecast (2017-2026)
      3. ADULTS (10-64 YEARS): Market Trends, Size, and Forecast (2017-2026)
      4. GERIATRICS (65 YEARS AND ABOVE): Market Trends, Size, and Forecast (2017-2026)
  9. Europe Analysis

    1. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Country, Y-O-Y Growth Analysis

      1. Introduction
      2. Germany: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Germany 23-Valent Pneumococcal Polysaccharide Vaccine Market: Dose Type
        3. Germany 23-Valent Pneumococcal Polysaccharide Vaccine Market: Age-group
      3. United Kingdom: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. United Kingdom 23-Valent Pneumococcal Polysaccharide Vaccine Market: Dose Type
        3. United Kingdom 23-Valent Pneumococcal Polysaccharide Vaccine Market: Age-group
      4. France: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. France 23-Valent Pneumococcal Polysaccharide Vaccine Market: Dose Type
        3. France 23-Valent Pneumococcal Polysaccharide Vaccine Market: Age-group
      5. Spain: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Spain 23-Valent Pneumococcal Polysaccharide Vaccine Market: Dose Type
        3. Spain 23-Valent Pneumococcal Polysaccharide Vaccine Market: Age-group
      6. Russia: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Russia 23-Valent Pneumococcal Polysaccharide Vaccine Market: Dose Type
        3. Russia 23-Valent Pneumococcal Polysaccharide Vaccine Market: Age-group
      7. Italy: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Italy 23-Valent Pneumococcal Polysaccharide Vaccine Market: Dose Type
        3. Italy 23-Valent Pneumococcal Polysaccharide Vaccine Market: Age-group
      8. Rest of Europe: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Rest of Europe 23-Valent Pneumococcal Polysaccharide Vaccine Market: Dose Type
        3. Rest of Europe 23-Valent Pneumococcal Polysaccharide Vaccine Market: Age-group
    2. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Dose Type, Y-O-Y Growth Analysis

      1. Introduction
      2. SINGLE DOSE VIAL: Market Trends, Size, and Forecast (2017-2026)
      3. PRE-FILLED SYRINGE: Market Trends, Size, and Forecast (2017-2026)
    3. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Age-group, Y-O-Y Growth Analysis

      1. Introduction
      2. CHILDREN (2-10 YEARS): Market Trends, Size, and Forecast (2017-2026)
      3. ADULTS (10-64 YEARS): Market Trends, Size, and Forecast (2017-2026)
      4. GERIATRICS (65 YEARS AND ABOVE): Market Trends, Size, and Forecast (2017-2026)
  10. Asia-Pacific Analysis

    1. Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Country, Y-O-Y Growth Analysis

      1. Introduction
      2. China: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. China 23-Valent Pneumococcal Polysaccharide Vaccine Market: Dose Type
        3. China 23-Valent Pneumococcal Polysaccharide Vaccine Market: Age-group
      3. Japan: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Japan 23-Valent Pneumococcal Polysaccharide Vaccine Market: Dose Type
        3. Japan 23-Valent Pneumococcal Polysaccharide Vaccine Market: Age-group
      4. India: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. India 23-Valent Pneumococcal Polysaccharide Vaccine Market: Dose Type
        3. India 23-Valent Pneumococcal Polysaccharide Vaccine Market: Age-group
      5. Southeast Asia: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Southeast Asia 23-Valent Pneumococcal Polysaccharide Vaccine Market: Dose Type
        3. Southeast Asia 23-Valent Pneumococcal Polysaccharide Vaccine Market: Age-group
      6. Australia & New Zealand: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Australia & New Zealand 23-Valent Pneumococcal Polysaccharide Vaccine Market: Dose Type
        3. Australia & New Zealand 23-Valent Pneumococcal Polysaccharide Vaccine Market: Age-group
      7. Rest of Asia-Pacific: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Rest of Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Market: Dose Type
        3. Rest of Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Market: Age-group
    2. Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Dose Type, Y-O-Y Growth Analysis

      1. Introduction
      2. SINGLE DOSE VIAL: Market Trends, Size, and Forecast (2017-2026)
      3. PRE-FILLED SYRINGE: Market Trends, Size, and Forecast (2017-2026)
    3. Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Age-group, Y-O-Y Growth Analysis

      1. Introduction
      2. CHILDREN (2-10 YEARS): Market Trends, Size, and Forecast (2017-2026)
      3. ADULTS (10-64 YEARS): Market Trends, Size, and Forecast (2017-2026)
      4. GERIATRICS (65 YEARS AND ABOVE): Market Trends, Size, and Forecast (2017-2026)
  11. Latin America Analysis

    1. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Country, Y-O-Y Growth Analysis

      1. Introduction
      2. Brazil: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Brazil 23-Valent Pneumococcal Polysaccharide Vaccine Market: Dose Type
        3. Brazil 23-Valent Pneumococcal Polysaccharide Vaccine Market: Age-group
      3. Argentina: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Argentina 23-Valent Pneumococcal Polysaccharide Vaccine Market: Dose Type
        3. Argentina 23-Valent Pneumococcal Polysaccharide Vaccine Market: Age-group
      4. Mexico: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Mexico 23-Valent Pneumococcal Polysaccharide Vaccine Market: Dose Type
        3. Mexico 23-Valent Pneumococcal Polysaccharide Vaccine Market: Age-group
      5. Colombia: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Colombia 23-Valent Pneumococcal Polysaccharide Vaccine Market: Dose Type
        3. Colombia 23-Valent Pneumococcal Polysaccharide Vaccine Market: Age-group
      6. Rest of Latin America: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Rest of Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Market: Dose Type
        3. Rest of Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Market: Age-group
    2. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Dose Type, Y-O-Y Growth Analysis

      1. Introduction
      2. SINGLE DOSE VIAL: Market Trends, Size, and Forecast (2017-2026)
      3. PRE-FILLED SYRINGE: Market Trends, Size, and Forecast (2017-2026)
    3. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Age-group, Y-O-Y Growth Analysis

      1. Introduction
      2. CHILDREN (2-10 YEARS): Market Trends, Size, and Forecast (2017-2026)
      3. ADULTS (10-64 YEARS): Market Trends, Size, and Forecast (2017-2026)
      4. GERIATRICS (65 YEARS AND ABOVE): Market Trends, Size, and Forecast (2017-2026)
  12. Middle East & Africa Analysis

    1. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Country, Y-O-Y Growth Analysis

      1. Introduction
      2. Middle East: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Middle East 23-Valent Pneumococcal Polysaccharide Vaccine Market: Dose Type
        3. Middle East 23-Valent Pneumococcal Polysaccharide Vaccine Market: Age-group
      3. Africa: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Africa 23-Valent Pneumococcal Polysaccharide Vaccine Market: Dose Type
        3. Africa 23-Valent Pneumococcal Polysaccharide Vaccine Market: Age-group
      4. Rest of Middle East & Africa: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Rest of Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Market: Dose Type
        3. Rest of Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Market: Age-group
    2. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Dose Type, Y-O-Y Growth Analysis

      1. Introduction
      2. SINGLE DOSE VIAL: Market Trends, Size, and Forecast (2017-2026)
      3. PRE-FILLED SYRINGE: Market Trends, Size, and Forecast (2017-2026)
    3. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Age-group, Y-O-Y Growth Analysis

      1. Introduction
      2. CHILDREN (2-10 YEARS): Market Trends, Size, and Forecast (2017-2026)
      3. ADULTS (10-64 YEARS): Market Trends, Size, and Forecast (2017-2026)
      4. GERIATRICS (65 YEARS AND ABOVE): Market Trends, Size, and Forecast (2017-2026)
  13. 23-Valent Pneumococcal Polysaccharide Vaccine Market: Company Analysis

    1. Introduction
    2. PFIZER INC.

      1. Overview
      2. Business Portfolio
      3. Product Portfolio
      4. Key Brands Insights
      5. Company SWOT & Strategic Analysis
      6. Company Financials
      7. Analyst Insights
    3. SANOFI S.A.

    4. GLAXOSMITHKLINE PLC

    5. MERCK & CO.

    6. ASTRAZENECA

    7. BAXTER INTERNATIONAL INC.

    8. BEIJING MINHAI BIOTECHNOLOGY

    9. SERUM INSTITUTE OF INDIA

    10. BIOGEN INC.

    11. ELI LILLY AND COMPANY

  14. 23-Valent Pneumococcal Polysaccharide Vaccine Market: Competitive Analysis

    1. Strategic Dashboard of Top Market Players
    2. Companies Deals (Mergers, Partnerships, Acquisitions, JVs)
    3. Expansion Areas (Based on Company Analysis)
    4. Market Share Analysis
  15. 23-Valent Pneumococcal Polysaccharide Vaccine Market: Distribution Channel Analysis

    1. Distributor Type Analysis
    2. Major Distributors (Key Countries)
    3. Future Growth Prospects
  16. Industry & Analysts Insights for Success

  17. Research Methodology

  18. Appendix

    1. List of Tables
    2. List of Figures
    3. Available Customizations
    4. Related Reports

List of Figures

Figure 1: Global 23-Valent Pneumococcal Polysaccharide Vaccine Market: Structure

Figure 2: Global 23-Valent Pneumococcal Polysaccharide Vaccine Market: Value Chain Analysis

Figure 3: Global 23-Valent Pneumococcal Polysaccharide Vaccine Market: Porter's Five Forces Model

Figure 4: Global 23-Valent Pneumococcal Polysaccharide Vaccine Market: Market Dynamics

Figure 5: Global 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Dose Type, 2016-2026 (USD Million)

Figure 6: Global 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Age-group, 2016-2026 (USD Million)

Figure 7: Global 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Region, 2016-2026 (USD Million)

Figure 8: North America 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Dose Type, 2016-2026 (USD Million)

Figure 9: North America 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Age-group, 2016-2026 (USD Million)

Figure 10: North America 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Country, 2016-2026 (USD Million)

Figure 11: Europe 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Dose Type, 2016-2026 (USD Million)

Figure 12: Europe 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Age-group, 2016-2026 (USD Million)

Figure 13: Europe 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Country, 2016-2026 (USD Million)

Figure 14: Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Dose Type, 2016-2026 (USD Million)

Figure 15: Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Age-group, 2016-2026 (USD Million)

Figure 16: Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Country, 2016-2026 (USD Million)

Figure 17: Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Dose Type, 2016-2026 (USD Million)

Figure 18: Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Age-group, 2016-2026 (USD Million)

Figure 19: Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Country, 2016-2026 (USD Million)

Figure 20: Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Dose Type, 2016-2026 (USD Million)

Figure 21: Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Age-group, 2016-2026 (USD Million)

Figure 22: Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Country, 2016-2026 (USD Million)

List of Tables

Table 1: Global 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Dose Type, 2017-2026 (USD Million)

Table 2: Global 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Age-group, 2017-2026 (USD Million)

Table 3: Global 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Region, 2017-2026 (USD Million)

Table 4: North America 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Dose Type, 2016-2026 (USD Million)

Table 5: North America 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Age-group, 2016-2026 (USD Million)

Table 6: North America 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Country, 2016-2026 (USD Million)

Table 7: United States 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Dose Type, 2016-2026 (USD Million)

Table 8: United States 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Age-group, 2016-2026 (USD Million)

Table 9: Canada 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Dose Type, 2016-2026 (USD Million)

Table 10: Canada 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Age-group, 2016-2026 (USD Million)

Table 11: Europe 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Dose Type, 2016-2026 (USD Million)

Table 12: Europe 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Age-group, 2016-2026 (USD Million)

Table 13: Europe 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Country, 2016-2026 (USD Million)

Table 14: Germany 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Dose Type, 2016-2026 (USD Million)

Table 15: Germany 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Age-group, 2016-2026 (USD Million)

Table 16: United Kingdom 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Dose Type, 2016-2026 (USD Million)

Table 17: United Kingdom 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Age-group, 2016-2026 (USD Million)

Table 18: France 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Dose Type, 2016-2026 (USD Million)

Table 19: France 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Age-group, 2016-2026 (USD Million)

Table 20: Spain 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Dose Type, 2016-2026 (USD Million)

Table 21: Spain 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Age-group, 2016-2026 (USD Million)

Table 22: Russia 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Dose Type, 2016-2026 (USD Million)

Table 23: Russia 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Age-group, 2016-2026 (USD Million)

Table 24: Italy 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Dose Type, 2016-2026 (USD Million)

Table 25: Italy 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Age-group, 2016-2026 (USD Million)

Table 26: Rest of Europe 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Dose Type, 2016-2026 (USD Million)

Table 27: Rest of Europe 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Age-group, 2016-2026 (USD Million)

Table 28: Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Dose Type, 2016-2026 (USD Million)

Table 29: Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Age-group, 2016-2026 (USD Million)

Table 30: Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Country, 2016-2026 (USD Million)

Table 31: China 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Dose Type, 2016-2026 (USD Million)

Table 32: China 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Age-group, 2016-2026 (USD Million)

Table 33: Japan 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Dose Type, 2016-2026 (USD Million)

Table 34: Japan 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Age-group, 2016-2026 (USD Million)

Table 35: India 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Dose Type, 2016-2026 (USD Million)

Table 36: India 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Age-group, 2016-2026 (USD Million)

Table 37: Southeast Asia 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Dose Type, 2016-2026 (USD Million)

Table 38: Southeast Asia 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Age-group, 2016-2026 (USD Million)

Table 39: Australia & New Zealand 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Dose Type, 2016-2026 (USD Million)

Table 40: Australia & New Zealand 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Age-group, 2016-2026 (USD Million)

Table 41: Rest of Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Dose Type, 2016-2026 (USD Million)

Table 42: Rest of Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Age-group, 2016-2026 (USD Million)

Table 43: Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Dose Type, 2016-2026 (USD Million)

Table 44: Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Age-group, 2016-2026 (USD Million)

Table 45: Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Country, 2016-2026 (USD Million)

Table 46: Brazil 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Dose Type, 2016-2026 (USD Million)

Table 47: Brazil 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Age-group, 2016-2026 (USD Million)

Table 48: Argentina 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Dose Type, 2016-2026 (USD Million)

Table 49: Argentina 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Age-group, 2016-2026 (USD Million)

Table 50: Mexico 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Dose Type, 2016-2026 (USD Million)

Table 51: Mexico 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Age-group, 2016-2026 (USD Million)

Table 52: Colombia 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Dose Type, 2016-2026 (USD Million)

Table 53: Colombia 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Age-group, 2016-2026 (USD Million)

Table 54: Rest of Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Dose Type, 2016-2026 (USD Million)

Table 55: Rest of Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Age-group, 2016-2026 (USD Million)

Table 56: Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Dose Type, 2016-2026 (USD Million)

Table 57: Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Age-group, 2016-2026 (USD Million)

Table 58: Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Country, 2016-2026 (USD Million)

Table 59: Middle East 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Dose Type, 2016-2026 (USD Million)

Table 60: Middle East 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Age-group, 2016-2026 (USD Million)

Table 61: Africa 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Dose Type, 2016-2026 (USD Million)

Table 62: Africa 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Age-group, 2016-2026 (USD Million)

Table 63: Rest of Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Dose Type, 2016-2026 (USD Million)

Table 64: Rest of Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Age-group, 2016-2026 (USD Million)